BooksTestimonialsInterviewsLibraryArticlesShop Here 


Library of Scientific Studies Funded and Published by others and Hepatitis C articles from other sources..

cannabis use on severity of hepatitis C disease (2008)


BACKGROUND & AIMS: Complications of HCV infection are primarily related to the development of advanced fibrosis and whether cannabis use is a risk factor for more severe fibrosis is controversial.

METHODS: Baseline data from a prospective cohort study of 204 persons with chronic HCV infection were used for analysis. The outcome was fibrosis score on biopsy, and the primary predictor evaluated was daily cannabis use.

Dark Times for Herbal Medicine in Europe

Our European Office, is preparing for a legal challenge against EU herb laws.

As we reported to you last November, thousands of products associated with traditional medicine will soon become illegal throughout the European Union (EU). And more and more, EU legislation influences US domestic policy, especially where health-related laws are concerned. The EU threat to herbal medicine is real, and we urge you to take stock of what’s going on so we can collectively jump in the minute anything similar emerges from US regulators. After all, it was that joint action from consumers and health organizations back in 1994 that has kept US regulations over dietary supplements relatively sane. But let’s not forget that this kind of freedom needs to be fought for every step of the way.

Here’s what our colleagues in the ANH Europe office are able to relay to you.

The EU has passed a stunning 139,338 directives, regulations and decisions since 1980. While it previously allowed European countries (now referred to as EU “member states”) to make up their own rules controlling natural healthcare products, there has been a push since around 2000 to control this area by rules formulated primarily by unelected bureaucrats in Brussels.

One of the laws that is set to devastate herbal medicines and products EU-wide, the Traditional Herbal Medicinal Products Directive (THMPD, also known as Directive 2004/24/EC) successfully passed into European law back in 2004. The law will be implemented fully on May 1 this year, and ANH-Intl has exhausted all options other than legal challenge in its efforts to protect the fundamental rights and freedoms of European citizens.

Chronic Hep C and Cardiovascular Health

People with chronic Hepatitis C infection are known to have an elevated risk for cardiovascular disease. Despite this understanding, the usual markers of cardiovascular disease may not necessarily apply to those with Hepatitis C. This is because the circulatory systems of people with Hepatitis C appear to contain less fat than the general population; however, there is sufficient evidence associating this chronic liver virus with atherosclerosis.

As if the Hepatitis C virus taking up residence in the liver isn't enough to contend with, it also raises the risk for cardiovascular disease - the number one killer in America. Cardiovascular diseases are conditions that affect the heart and blood vessels, such as heart disease, high blood pressure, high cholesterol, deep vein thrombosis and stroke. Knowing the risks for cardiovascular disease can help people maintain their heart and blood vessel health, detect an emerging problem and successfully manage existing conditions.

The Usual Suspects
The primary cause of cardiovascular disease is atherosclerosis, otherwise known as hardening of the arteries. Atherosclerosis is a process in which deposits of fatty substances, cholesterol, cellular waste products, calcium and other substances build up in the inner lining of an artery. Called plaque, this buildup can grow large enough to significantly reduce the blood's flow through an artery.

There is a long list of risks for developing atherosclerosis, including genetics, blood health markers, high blood pressure, other co-existing diseases, smoking, activity level, obesity and diet. However, hyperlipidemia is traditionally one of the most important risk factors for atherosclerosis. Hyperlipidemia is an elevation of lipids (fats) in the bloodstream. These lipids include cholesterol, cholesterol esters (compounds), phospholipids and triglycerides. Individuals who are considered to be at the highest risk for cardiovascular disease have atherosclerosis and hyperlipidemia.

Post Interferon Treatment Survey


Executive Summary
The Hepatitis C Trust held a web-based survey from April 2006 to September 2007 that asked about people’s experience of anti-viral hepatitis C treatment and in particular how they felt up to 3 years after finishing the treatment. 500 respondents completed the questionnaire.

Key findings:

* 90% of people reported ongoing symptoms/side effects for longer than 12 months after treatment ended.
* The five most frequently reported post treatment symptoms/side effects were fatigue, joint aches/pains, brain fog, depression and mood swings.
* Regardless of SVR (sustained virological response), 40% of people felt worse after treatment than before and 31% felt better.
For those who had attained SVR
37% felt better and 36% felt worse

7 VITAL Actions for 2011

So Many Threats, So Little Time! 
Here's a List of Vital
Actions for 2011
Forward them to All Your Contacts
So They Can Do the Same.

Immune system boost cures HIV-like infections

A group of Australian scientists have been able to cure HIV-like infections in mice by boosting their immune systems.

Doctor Marc Pellegrini from Melbourne's Walter and Eliza Hall Institute found a hormone known as Interleukin 7 stimulates the body's response to an infection, causing it to clear the virus.

This process is called immune exhaustion.

"We found that Interleukin 7 boosted the immune response in a pretty profound fashion, such that animals were able to gradually clear the virus without too much collateral tissue damage," Dr Pellegrini said.

Zero Deaths from Vitamins, Minerals, Amino Acids or Herbs

Poison Control Statistics Prove Supplements' Safety Yet Again

(OMNS Jan 5, 2011) There was not even one death caused by a dietary supplement in 2009, according to the most recent information collected by the U.S. National Poison Data System.

The new 200-page annual report of the American Association of Poison Control Centers, published in the journal Clinical Toxicology, shows zero deaths from multiple vitamins; zero deaths from any of the B vitamins; zero deaths from vitamins A, C, D, or E; and zero deaths from any other vitamin.

Additionally, there were no deaths whatsoever from any amino acid, herb, or dietary mineral supplement. 

Two people died from non-nutritional mineral poisoning, one from a sodium salt and one from an iron salt or iron. On page 1139, the AAPCC report specifically indicates that the iron fatality was not from a nutritional supplement. One other person is alleged to have died from an "Unknown Dietary Supplement or Homeopathic Agent." This claim remains speculative, as no verification information was provided.

60 poison centers provide coast-to-coast data for the U.S. National Poison Data System, "one of the few real-time national surveillance systems in existence, providing a model public health surveillance system for all types of exposures, public health event identification, resilience response and situational awareness tracking."

Over half of the U.S. population takes daily nutritional supplements. Even if each of those people took only one single tablet daily, that makes 155,000,000 individual doses per day, for a total of nearly 57 billion doses annually. Since many persons take more than just one vitamin or mineral tablet, actual consumption is considerably higher, and the safety of nutritional supplements is all the more remarkable.

If nutritional supplements are allegedly so "dangerous," as the FDA and news media so often claim,
where are the bodies?

Syndicate content